M&A Deal Summary |
|
|---|---|
| Date | 2020-01-09 |
| Target | Amerigen Pharmaceuticals - Commercial and Pipeline Generic Products |
| Sector | Medical Products |
| Buyer(s) | ANI Pharmaceuticals |
| Sellers(s) | Amerigen |
| Deal Type | Divestiture |
| Deal Value | 53M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2001 |
| Sector | Life Science |
| Employees | 897 |
| Revenue | 614M USD (2024) |
ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 15 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 11 of 11 |
| Country: China M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Size (of disclosed) | 4 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-06-18 |
Coeptis Pharmaceuticals - Seven Development Stage Drug Products
Wexford, Pennsylvania, United States Coeptis Pharmaceuticals, Inc. - Seven Development Stage Drug Products includes three oral and four injectable products and has a combined current annual U.S. market value of $1.02 billion according to IQVIA and ANI estimates. Six of the products are currently in development at third parties with commercial manufacturing sites already established. The seventh product, a liposomal-based injectable, is in development at a third party and ANI will seek to identify a commercial manufacturing partner in the near-term. |
Buy | $14M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-09 |
Novitium Pharma
East Windsor, New Jersey, United States With operations in East Windsor, New Jersey, and Chennai, India, Novitium Pharma is a U.S.-based pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The Company, founded in 2016, by Samy Shanmugam, Chad Gassert, and Vijay Thorappadi, has since developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. |
Buy | $164M |
Amerigen is a developer, manufacturer, and distributor of generic pharmaceutical products. Amerigen was founded in 2007 and is based in Lyndhurst, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
